Fluorescence in situ hybridization on Peripheral blood for Chronic Myeloid Leukaemia - Rapid and reliable method

Abstract

Philadelphia chromosome (Ph) is found in more than 95% of Chronic Myeloid Leukaemia (CML) patients arising from the reciprocal translocation of chromosomes 9 and 22 which results in the formation of chimeric fusion gene BCR-ABL. This paved the path for targeted gene therapy in CML and thus plays a pivotal role in diagnosis and prognosis. Fluorescence in situ hybridization (FISH) is a rapid and reliable technique in molecular cytogenetics to detect BCR-ABL fusion signal in both interphase and metaphase spreads of bone marrow sample. Peripheral blood white cells as a surrogate for bone marrow have been suggested by a few studies.

The objective of the study was to evaluate FISH on peripheral blood specimen as a rapid and reliable method to quantify Ph positive cells in a patient with Chronic Myeloid Leukaemia. FISH was performed on interphase nuclei from cultured peripheral blood sample of the patient using BCR/ABL Translocation, Dual fusion probe. Chromosomal analysis was performed by GTG banding technique. FISH and karyotyping confirmed the presence of reciprocal translocation t (9; 12) (q34.1; q11.2).

Our results confirmed that FISH technique is a rapid, sensitive, quantitative technique which can be used for the evaluation of CML using peripheral blood. FISH helps in the detection of minimal residual disease and disease recurrence with small percentage of abnormal cells. In our experience, this situation is usually associated with very high WBC count which can result in increase in the percentage of Phpositive cells.

Keywords

Fluorescence in situ hybridization (FISH) - chromosomal analysis - chronic myeloid leukemia - peripheral blood

• References

• 1 Subramaniyan PG. Cytogenetic study in CML. Indian J Med Res. 2012;135:12-13.
• 2 Jha CB, Kucheria K, Choudhary VP. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (fish) in chronic myeloid leukemia patients. Kathmandu University Medical Journal. 2006;4(2):171-175.
• 3 Reena RMZ, Julia Munchar MJ, Salwati S, Zubaidah Z, Hamidah NH, Sharifah NA, Cheong SK. Detection of BCR/ABL Gene in Chronic Myeloid Leukaemia: Comparison of Fluorescence in situ Hybridisation (FISH), Conventional Cytogenetics and Polymerase Chain Reaction (PCR) Techniques. Med & Health. 2006;1(1):5-13.
• 4 Anand MS, Varma N, Varma S, Rana KS, Malhotra P. Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India. IJM R. 2012;135:42-48
• 5 Madon P, Athalye A, Bandkar V, Dhumal S, Sopariwala A, Parikh F. Fluorescence in-situ Hybridization (FISH) – A Rapid and Useful Technique for Diagnosis and Management in Leukemia. Int J Hum Genet. 2003;3(2):115-119.
• 6 Le Gouill S, Talmant P, Milpied N, Daviet A, Ancelot M, Moreau P, Harousseau JL, Bataille R, Avet-Loiseau H. Fluorescence In Situ Hybridization on Peripheral-Blood Specimens Is a Reliable Method to References Evaluate Cytogenetic Response in Chronic Myeloid Leukemia. Journal of Clinical Oncology. 2000;18(7):1533-1538.
• 7 Landstrom AP, Ketterling RP, Knudson RA, Tefferi A. Utility of peripheral blood dual color, double fusion fluorescent in situ hybridization for BCR/ABL fusion to assess cytogenetic remission status in chronic myeloid leukemia. Leukemia & Lymphoma. 2006;47(10):2055-2061. DOI: 10.1080/10428190600783551
• 8 Lim TH, Tien SL, Lim P, Lim AST. The Incidence and Patterns of BCR/ABL Rearrangements in Chronic Myeloid Leukaemia (CML) Using Fluorescence in-situ Hybridization (FISH). Ann Acad Med Singapore. 2005;34:533-538.
• 9 Testoni N, Marzocchi G, Luatti S, Amabile M, Baldazzi C, Stacchini M, et al,. Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the G IMEMA CMLWP. BLOOD. 2009; 14 (24): 4939 - 4943. doi:10.1182/blood-2009-07-229864.
• 10 Patel BP, Trivedi PJ, Brahmbhatt MM, Gajjar SB, Iyer RR, Dalal EN, Shukla SN, Shah PM. Deletion of derivative ABL, BCR or ABL-BCR fusion gene is associated with shorter disease free survival in CML patients. Int. J. Genet. Mol. Biol. 2010;2(7):158-164.